Cargando…
miR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer
Estrogen receptor-α (ERα) is essential for estrogen-dependent growth and its level of expression is a crucial determinant of response to endocrine therapy and prognosis in ERα-positive breast cancer. Breast cancer patients show a wide range of ERα expression levels which change in individual patient...
Autores principales: | HE, YUE-JUN, WU, JIAN-ZHONG, JI, MING-HUA, MA, TAO, QIAO, EN-QI, MA, RONG, TANG, JIN-HAI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570195/ https://www.ncbi.nlm.nih.gov/pubmed/23408138 http://dx.doi.org/10.3892/etm.2013.915 |
Ejemplares similares
-
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
por: Cittelly, Diana M, et al.
Publicado: (2010) -
Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia
por: Fayyad-Kazan, Hussein, et al.
Publicado: (2013) -
Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia
por: Elhamamsy, Amr Rafat, et al.
Publicado: (2017) -
Tumor Suppressive Role of miR-342-5p and miR-491-5p in Human Osteosarcoma Cells
por: Veys, Clément, et al.
Publicado: (2022) -
miR-342 inhibits glioma cell proliferation by targeting GPRC5A
por: Wang, Jianjiao, et al.
Publicado: (2019)